Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma
Combination therapy superior with respect to progression-free, overall survival and overall response for first-line treatment of advanced RCC.
Combination therapy superior with respect to progression-free, overall survival and overall response for first-line treatment of advanced RCC.
Approved prostate cancer drug treatments including formulations and usual dosing.
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
FDA-approved oral and injectable treatment options for breast cancer.
A comparative list of treatment options for arthritis including DMARDS and other immune modulators.
Oral antibiotics for urinary tract infections (UTIs) treatment chart including dosing and duration.
Erectile dysfunction treatment chart including onset time, duration of action, and dosing for each drug product.
Sedative-hypnotic medications daily dose threshold chart, especially for long term care patients.
FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma.